DexCom, Inc. (DXCM)
72.22
-1.21
(-1.65%)
USD |
NASDAQ |
Mar 02, 12:03
DexCom EPS Diluted (Quarterly) : 0.6761 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| BioLife Solutions, Inc. | 0.0152 |
| Abbott Laboratories | 1.030 |
| Insulet Corp. | 1.441 |
| Krystal Biotech, Inc. | 1.699 |
| Boston Scientific Corp. | 0.4493 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 267.30M |
| Revenue (Quarterly) | 1.260B |
| Total Expenses (Quarterly) | 992.30M |
| Enterprise Value | 27.65B |
| Gross Profit Margin (Quarterly) | 62.93% |
| Profit Margin (Quarterly) | 21.22% |
| Earnings Yield | 2.90% |
| Operating Earnings Yield | 3.11% |
| Normalized Earnings Yield | 2.898 |